Published: Jun 06, 2019
By: DSN Staff
LifeVantage (LFVN) opened for business in Belgium, marking the company’s third European market launch in as many months.
“Our expansion strategy in Europe has been deliberate and aggressive, particularly this calendar year,” said LifeVantage CEO Darren Jensen. “It’s indicative of the traction the LifeVantage biohacking movement continues to gain in that part of the world, and we’re thrilled to now officially count the people of Belgium among our growing biohacking community.”
Select LifeVantage products have been offered in Belgium on a not-for-resale basis for approximately a year as part of the company’s Global Customer Acquisition Program. During that time, the country demonstrated consistent growth as a customer market, paving the way for the company to now open for distributor enrollments as well. It’s a blueprint that has helped drive much of the company’s recent growth and expansion in Europe.
“As a company, this model has allowed us to build a presence and customer base throughout Europe, which, in turn, is enabling current and new distributors to really hit the ground running in these respective European countries as they open,” said LifeVantage Chief Sales Officer Justin Rose.
LifeVantage opened in Austria in September, Spain in March, and Ireland in May. With the addition of Belgium, LifeVantage now serves 15 markets in North America, Europe, Australia, and Asia.